Ontario Agency for Health Protection and Promotion
11
0
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Does the 'CATCH My Breath' Vaping Prevention Program Prevent High School Students in Ontario, Canada From Starting to Vape?
Role: collaborator
Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity
Role: collaborator
Do Fair Comparisons or Harms Data Increase Responsiveness to Feedback About Antibiotic Prescribing: 2x2 Factorial Trial
Role: collaborator
Does Inclusion of Viral Prescription Pad Resources Increase Responsiveness to Feedback About Antibiotic Prescribing in Primary Care
Role: collaborator
Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term Care (FIRST AID -LTC) - Phase 2
Role: collaborator
Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term Care
Role: collaborator
Providing Antibiotic Prescribing Feedback to Primary Care Physicians: The Ontario Program To Improve AntiMicrobial USE
Role: lead
An Urban Trail Network and Cardiovascular Disease: A Natural Experiment
Role: collaborator
Evaluation of Enhanced Syphilis Screening Among HIV-positive Men
Role: collaborator
The Association Between Food Insecurity and Incident Type 2 Diabetes in Canada: A Population-based Cohort Study
Role: collaborator
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools
Role: collaborator
All 11 trials loaded